
Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …

Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …
BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …
A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
Spanish pharma company Almirall has opened its new UK and Ireland headquarters in West London's Stockley Park.The site will be …
Spanish pharma company Almirall is in discussions with potential partners for one of its asthma drugs following positive trial results. …
Almirall has been Spain's number one pharmaceutical company for some years, but is still little known outside its home market. …